Based on investigation of the HER2 status of tumors and CTCs, we identified 13 patients with HER2 expression in tumor tissues (group A), eight patients with HER2 expression in CTCs despite no HER2 expression in tumor tissues (group B), and six patients without HER2 expression in tumors or CTCs (group C). Here, ERBB2 is linked to neoplasm.